Macrovascular outcomes and mortality after bariatric surgery in patients with metabolic dysfunction–associated steatotic liver disease, and Type 2 diabetes
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease globally, with a significant association between MASLD and Type 2 diabetes mellitus (T2DM), obesity, and cardiovascular disease (CVD). While bariatric surgery (BS) has sho...
Saved in:
| Main Authors: | Arunkumar Krishnan, Carolin V. Schneider, Diptasree Mukherjee, Tinsay A. Woreta, Saleh A. Alqahtani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Diabetology & Metabolic Syndrome |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13098-025-01767-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reply to correspondence on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
by: Jing Zeng, et al.
Published: (2025-04-01) -
Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
by: Weixiong Zhu, et al.
Published: (2025-07-01) -
A leap in the dark: Bariatric surgery for treatment of metabolic dysfunction-associated steatotic liver disease related cirrhosis: Editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
by: Jing Zeng, et al.
Published: (2025-04-01) -
Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis
by: Nicholas A. Rouillard, et al.
Published: (2025-01-01) -
Association of Index and Changes in Fibrosis-4 Score With Outcomes in Metabolic Dysfunction-Associated Steatohepatitis
by: Semiu O. Gbadamosi, et al.
Published: (2025-01-01)